Tirzepatide : Marketed as Mounjaro (diabetes) and Zepbound (obesity), tirzepatide combines GLP-1 and GIP receptor agonism, achieving up to 22% weight loss , the highest among approved drugs
After adjustment of the model for weight loss, associations between the groups and headache outcomes did not remain statistically significant although a trend towards better headache outcomes in the GLP-1-RA group was noted
In our study, we confirmed that ACTL6A is a cotranscription factor in the NRF2-dependent regulation of GCLC
Donepezil, an acetylcholinesterase inhibitor, has shown promising results in mitigating cardiotoxicity induced by chemotherapeutic agents like doxorubicin and trastuzumab
Understanding the tier structure prevents confusion during these transitions
Differentiating unipolar and bipolar depression by alterations in large-scale brain networks